BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Proteus Biomedical, Inc. Raises $17.5 Million


5/17/2012 8:50:53 AM

Here are fundings from Silicon Valley companies, announced or filed recently with the U.S. Securities and Exchange Commission.

The Funded is a recurring feature where we post new fundings that cross our desks, as well as an archive of past fundings.

Proteus Biomedical Inc. raises $17.5M of $50M round

The Redwood City-based health care company sold equity to raise the funds. The parties listed on the filing include: Joy Berberich, executive; Benjamin Costello, executive; Lorenzo Di Carlo, executive; Frank Fischer, director; Terry Gould, director; Erika Karplus, executive; Alan Levy, director; David O'Reilly, executive; Ben Pless, director; Timothy Robertson, executive; George Savage, executive; Ryan Schwarz, director; Immanuel Thangaraj, director; Andrew Thompson, executive, director; Todd Thompson, executive; Mark Zdeblick, executive, director.

Proteus is a private company. Its investors include: Adams Street Partners, Asset Management, The Carlyle Group, Essex Woodlands, Fletcher Spaght Ventures LP, Kaiser Permanente Ventures and Spring Ridge Ventures. The company makes digestible sensors made from food ingredients, which can record information such as a drug type or dosage.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES